Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100

Melanoma Research

Volumn 7, Issue 6, 1997, Pages 463-470

  Schreurs, M W J ^a   De Boer, A J ^a   Schmidt, A ^a   Figdor, C G ^a   Adema, G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antigen expression; B16 melanoma; gp100; HMB 45; Immunotherapy; Mouse model; RT PCR

Indexed keywords

CELL ANTIGEN; MONOPHENOL MONOOXYGENASE;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CELL LINEAGE; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, NORTHERN; BLOTTING, WESTERN; CLONING, MOLECULAR; DNA, NEOPLASM; HUMANS; MELANOMA; MELANOMA, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; RNA, NEOPLASM; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0031413115     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199712000-00004     Document Type: Article

References (27)

1. Van Pel A, van der Bruggen P, Coulie PG, et al. Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev 1995; 145: 229-250.
2. Robbins PF, Kawakami Y. Human tumor antigens recognized by T cells. Curr Opin Immunol 1996; 8: 628-636.
3. Bakker ABH, Schreurs MWJ, De Boer AJ, et al. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Meet 1994; 179: 1005-1009.
4. Bakker ABH, Schreurs MWJ, Tafazzul G, et al. Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line. Int J Cancer 1995; 62: 97-102.
5. Kawakami Y, Eliyahu S, Jennings C, et al. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 1995; 154: 3961-3968.
6. Cox AL, Skipper J, Chen Y, et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994; 264: 716-719.
7. Bakker ABH, Marland G, De Boer AJ, et al. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res 1995; 55: 5330-5334.
8. Boon T, Coulie P, Marchand M, et al. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy. Important Adv Oncol 1994; 53-69.
9. Rosenberg SA, Kawakami Y, Robbins PF, et al. Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. Adv Cancer Res 1996; 70: 145-177.
10. Fidler IJ. Selection of successive tumor lines for metastasis. Nature 1973; 242: 148-149.
11. Tao T, Burger MM. Non-metastasizing variants selected from metastasizing melanoma cells. Nature 1977; 270: 437-438.
12. Bennett DC, Cooper PJ, Hart IR. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer 1987; 39: 414-418.
13. Sviderskaya EV, Wakeling WF, Bennett DC. A cloned, immortal line of murine melanoblasts inducible to differentiate to melanocytes. Development 1995; 121: 1547-1557.
14. Ruppert S, Muller G, Kwon B, et al. Multiple transcripts of the mouse tyrosinase gene are generated by alternative splicing. EMBOJ 1988; 7: 2715-2722.
15. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
16. Lin AY, Devaux B, Green A, et al. Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science 1990; 249: 677-679.
17. Adema GJ, De Boer AJ, van't Hullenaar R, et al. Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am J Pathot 1993; 143: 1579-1585.
18. Erba HP, Gunning P, Kedes L. Nucleotide sequence of the human T cytoskeletal actin mRNA: anomalous evolution of vertebrate non-muscle actin genes. Nucleic Acids Res 1986; 14: 5275-5294.
19. Vennegoor C, Hageman P, Van Nouhuijs H, et al. A monoclonal antibody specific for cells of the melanocyte lineage. Am J Pathol 1988; 130: 179-192.
20. Kwon BS, Kim KK, Halaban R, et al. Characterization of mouse Pmel 17 gene and silver locus. Pigment Cell Res 1994; 7: 394-397.
21. Adema GJ, De Boer AJ, Vogel AM, et al. Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem 1994; 269: 20126-20133.
22. Kwon BS, Halaban R, Ponnazhagan S, et al. Mouse silver mutation is caused by a single base insertion in the putative cytoplasmic domain of Pmel 17. Nucleic Acids Res 1995; 23: 154-158.
23. Chelly J, Concordet J, Kaplan J, et al. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 1989; 86: 2617-2621.
24. Kluppel M, Beermann F, Ruppert S, et al. The mouse tyrosinase promoter is sufficient for expression in melanocytes and in the pigmented epithelium of the retina. Proc Natl Acad Sci USA 1991; 88: 3777-3781.
25. Ganss R, Montoliu L, Monaghan AP, et al. A cell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice. EMBO J 1994; 13: 3083-3093.
26. Gown AM, Vogel AM, Hoak D, et al. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol 1986; 123: 195-203.
27. Vogel AM, Esclamado RM. Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody. Cancer Res 1988; 48: 1286-1294.